Does RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Cause Headache? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Headache have been filed in association with RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E. This represents 7.1% of all adverse event reports for RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E.
33
Reports of Headache with RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E
7.1%
of all RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E reports
0
Deaths
8
Hospitalizations
How Dangerous Is Headache From RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E?
Of the 33 reports, 8 (24.2%) required hospitalization.
Is Headache Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Cause?
Herpes zoster (112)
Pain (93)
Vaccination failure (74)
Rash (64)
Pyrexia (50)
Fatigue (48)
Drug ineffective (44)
Nausea (40)
Pain in extremity (38)
Arthralgia (36)
What Other Drugs Cause Headache?
ADALIMUMAB (19,891)
APREMILAST (17,024)
ETANERCEPT (14,253)
TREPROSTINIL (14,051)
METHOTREXATE (11,718)
TOFACITINIB (11,061)
RITUXIMAB (8,747)
TOCILIZUMAB (8,448)
INFLIXIMAB (8,387)
ABATACEPT (8,184)
Which RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E Alternatives Have Lower Headache Risk?
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs REGADENOSON
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs REGORAFENIB
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs REGORAFENIB\REGORAFENIB
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs RELATLIMAB
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E vs RELPAX